USPTO serial 99697445
LUMORA MD
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- SMITH, REBECCA A
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: 13 Oct 2026
Need help with LUMORA MD?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
Office Action issues
The USPTO found no current conflicts with registered marks, but noted several prior-filed pending applications that may potentially impact your registration. They also require a formal disclaimer for the term 'MD' as it is considered descriptive of your services.
Owner
Blue Skies MD LLC
Roy, WA, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Synthetic peptides for pharmaceutical purposes; Hormone replacement therapy preparations; Therapeutic agents for weight control and appetite suppression; Weight management supplements; Pharmaceutical preparations for skin care; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Hormones for medical purposes | ACTIVE | — |
| 009 | Downloadable mobile applications for retrieving and displaying health information; Downloadable mobile applications for tracking hormone levels, managing testosterone replacement therapy, providing information on hormone replacement therapy, monitoring peptide therapy progress; Downloadable mobile applications for for accessing patient portals in the field of health and hormone therapy; Downloadable mobile applications for Tracking weight and health | ACTIVE | — |
| 035 | Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Retail pharmacy services; On-line retail store services featuring Therapeutic agents for weight control and appetite suppression, Hormone replacement therapy preparations, Synthetic peptides for pharmaceutical purposes; On-line retail store services featuring medical preparations for hormone replacement, synthetic peptides, testosterone gels or injections | ACTIVE | — |
| 044 | Telemedicine services; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; Pharmacists' services to make up prescriptions; Prescription refill reminder services; Online medical consultations rendered in virtual environments; Consulting services in the field of hormone replacement therapy; Hormone replacement therapy services | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Jul 13, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 13, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jul 13, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 13, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Jul 10, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 12, 2026 | NWAP | NEW APPLICATION ENTERED |